Myopia

The first daily disposable silicone hydrogel soft contact lenses specifically designed for slowing the progression of myopia in children*1 are...

Recent conferences have offered fresh clinical insights into repeated low-level red-light (RLRL) therapy in myopia management. At this year’s Asia-Pacific...

A researcher at Queensland University of Technology (QUT) has secured significant funding to investigate the early warning signs of myopia...

HOYA Vision Care has announced new clinical evidence from three key clinical studies highlighting the impact of Defocus Incorporated Multiple...

ZEISS Vision Care is organising a webinar to help optometrists and eyecare professionals focus on the growing prevalence of myopia...

Repeated low-level red-light (RLRL) therapy has been included in the 2025 Myopia Consensus Statement released by the World Society of...

ZEISS Vision Care is bolstering its myopia management portfolio with the acquisition of Brighten Optix, a leading player in orthokeratology...

The first Australian data into the efficacy of repeated low-level red-light (RLRL) has been published in what is shaping to...

The Essilor Stellest lens, clinically proven to slow myopia progression in children,^1 has now been evaluated in two studies for...

The inventor of the Eyerising International repeated low-level red light (RLRL) therapy for myopia, Professor Mingguang He, has outlined “notable...